PROGENIS PHARMACEUTICALS
Who is PROGENIS PHARMACEUTICALS?
ProGenis Pharmaceuticals is focused on developing next generation RNA therapeutics that are more efficient, safer and accessible to treat inherited rare and acquired diseases. ProGenis is headquartered in Perth, Australia, and led by world-renowned experts with significant experience in RNA therapeu...See more
Industry & Specialities
Others
Countries of Operation
Australia
Headquarters:
Australia
Company Type:
SME
Company size:
11-50 Employees
Year Founded:
2021 (5 years)
Address:
3 BRODIE-HALL DR; SUITE 7 & 10; BENTLEY, WESTERN AUSTRALIA 6102, AU
Employees by Department
Key Decision Makers
Bal Poudel
Senior Scientist
Mert Burak Ozturk
Senior Scientist II
Carlos Aya Bonilla Bed Sc
Senior Scientist. Inflammation Program Lead
Employees by Seniority
C-level
1employees
Senior
3employees
Non-managers
1employees
Financials
LOW
spending power
Funding Status
Private
Associated Legal Entities
0 entities
Discover More Companies
Lookalike companies
Featured Lists
- SMEs in Singapore
- MNCs / Large Enterprises in Singapore
Frequently Asked Questions (FAQ)
- How long has PROGENIS PHARMACEUTICALS been operating for?
- What is the funding status of PROGENIS PHARMACEUTICALS?
- Where is PROGENIS PHARMACEUTICALS's headquarter?
- What PROGENIS PHARMACEUTICALS's spending power?
- Does PROGENIS PHARMACEUTICALS have a presence in the domain it operates in?